Apremilast in Psoriasis Patients With Serious Comorbidities: a Case Series and Systematic Review of Literature

INTRODUCTION: Patients with serious comorbidities are traditionally excluded from clinical trials. Apremilast is not contraindicated in active infections, malignancy and serious hepatic or renal impairment, but real-life data is needed to support this recommendation. OBJECTIVES: The aim of this pape...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsentemeidou, Aikaterini, Sotiriou, Elena, Sideris, Nikolaos, Bakirtzi, Katerina, Papadimitriou, Ilias, Lallas, Aimilios, Ioannides, Dimitrios, Vakirlis, Efstratios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681161/
https://www.ncbi.nlm.nih.gov/pubmed/36534526
http://dx.doi.org/10.5826/dpc.1204a179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681161/
https://www.ncbi.nlm.nih.gov/pubmed/36534526
http://dx.doi.org/10.5826/dpc.1204a179

Ejemplares similares